Global Juvenile Macular Degeneration Clinical Trials Review 2024, Featuring Lin Bioscience, Nanoscope Therapeutics, Alnylam Pharmaceuticals, Biophytis, Kubota Pharmaceutical and Nucleus Network
May 27, 2024 05:00 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Macular Degeneration (Stargardt Disease) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Global Decompensated Cirrhosis Clinical Trials Review 2024, by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
May 27, 2024 04:44 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Decompensated Cirrhosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
Epilepsy Global Clinical Trials Review 2024 - Top Companies Participating in Epilepsy Therapeutics Clinical Trials
May 27, 2024 04:37 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides...
Clinical Trial Supply and Logistics for Pharma market is projected to grow at a CAGR of 9.3% by 2034: Visiongain
May 27, 2024 04:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Clinical Trial Supply and Logistics Market for Pharma 2024-2034: Forecasts by Type (CTS Manufacturing, CTS Logistics & Distribution, CT Supply Chain,...
Global Wet (Neovascular / Exudative) Macular Degeneration Clinical Trials Review 2024
May 27, 2024 02:49 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Clinical Trial Monitoring 2-Day Online Training Course: July 29-30, 2024 - Understand the Importance of Compliance with the Latest GCP Standards
May 24, 2024 07:40 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" conference has been added to ResearchAndMarkets.com's offering. With regulatory inspectors increasingly...
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
May 16, 2024 07:00 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
May 15, 2024 10:00 ET
|
Novartis Pharma AG
Primary results of the Scemblix® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the...
Citeline Introduces Global Patient Insights
May 15, 2024 09:00 ET
|
Citeline
Citeline announces the launch of Global Patient Insights, the industry’s most comprehensive view of the worldwide patient landscape.
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024 08:05 ET
|
Third Harmonic Bio
U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership...